Anastasios E. Germenis

ORCID: 0000-0002-3315-6947 · 2 papers in corpus

guideline 2025

Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment

Clinical reviews in allergy & immunology ·doi:10.1007/s12016-025-09027-4

Hereditary angioedema (HAE) has been recognized for almost 150 years. The newest form of HAE, where C1 inhibitor levels are normal (HAE-nC1INH), was first described in 2000. Over the last two decades, new types of apparent non-mast cell-med…

other 2024

Hereditary angioedema with normal C1 inhibitor associated with carboxypeptidase N deficiency

The journal of allergy and clinical immunology. Global ·doi:10.1016/j.jacig.2024.100223

BACKGROUND: Hereditary angioedema (HAE) is a potentially life-threatening disorder characterized by recurrent episodes of subcutaneous or submucosal swelling. HAE with normal C1 inhibitor (HAE-nC1-INH) is an underdiagnosed condition. Althou…